Here's Shouldn'T Asana: Why You Shouldn't Buy the Dip
Asana has fallen from pandemic highs, but buying the dip isn’t a guaranteed win. This guide explains the risks, what ...
Which No Annual Fee Credit Cards Earn Points
Learn about no annual fee credit cards that allow you to earn points. Start benefiting from your spending today!
25,023 articles
Chamath Palihapitiya Says Boom Sparks Capital Debate
As AI spending hits record levels, Chamath Palihapitiya argues the real test is whether buyers of AI can deliver dura...
Investors Just Subtle Warning From the Fed: What Comes Next
A quiet signal from the Federal Reserve is shaking up how investors think about risk. This article breaks down what t...
Zoom Eric Yuan Sells Shares: What Investors Should Know
When a company’s founder or CEO sells a chunk of stock, it sparks questions. This article breaks down the Zoom inside...
Palo Alto Networks’ Stock Slips After Earnings; Analysts Buy
Palo Alto Networks’ stock fell after the latest earnings, as traders weighed a murky near-term outlook against the co...
Tech Stocks February: Top 3 Buys for Investors Right Now
February can be a pivotal month for tech investing. This guide reveals three top tech stocks february to consider, pl...
Gigacloud (GCT) 2025 Earnings Outlook for Investors
Dive into gigacloud (gct) 2025 earnings with a clear, actionable analysis. We break down the Q4 results, growth drive...
Intelligent Alpha Mag-7: Google and Apple Lead Personal AI
The Intelligent Alpha CEO unveils the Mag-7, spotlighting Google and Apple as the central players in the personal AI ...
Don’t Blame AI for Weak Jobs Data, Economists Say Now
February’s jobs data showed a modest payroll gain, but economists say AI is not the main driver of the softness. The ...
Most Promising Industries Class for Today’s Grads in 2026
Six sectors are signaling strong hiring for today’s graduates. A new market analysis highlights healthcare, software,...
Record AI Orders Push Dell to Strong $33.4B Quarter
Dell Technologies rode a wave of AI server demand to a $33.4 billion quarterly revenue, beating expectations and lift...
Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status